CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 45  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0780
LYS 10.0199
GLU 20.0144
LEU 30.0089
ARG 40.0129
CYS 50.0078
GLN 60.0116
CYS 70.0270
ILE 80.0300
LYS 90.0296
THR 100.0159
TYR 110.0216
SER 120.0335
LYS 130.0345
PRO 140.0262
PHE 150.0239
HIS 160.0308
PRO 170.0207
LYS 180.0293
PHE 190.0260
ILE 200.0207
LYS 210.0287
GLU 220.0308
LEU 230.0061
ARG 240.0066
VAL 250.0146
ILE 260.0135
GLU 270.0084
SER 280.0064
GLY 290.0192
PRO 300.0237
HIS 310.0247
CYS 320.0262
ALA 330.0621
ASN 340.0085
THR 350.0152
GLU 360.0112
ILE 370.0071
ILE 380.0088
VAL 390.0183
LYS 400.0241
LEU 410.0179
SER 420.0101
ASP 430.0780
GLY 440.0428
ARG 450.0428
GLU 460.0305
LEU 470.0257
CYS 480.0076
LEU 490.0068
ASP 500.0161
PRO 510.0181
LYS 520.0447
GLU 530.0157
ASN 540.0264
TRP 550.0112
VAL 560.0095
GLN 570.0162
ARG 580.0283
VAL 590.0188
VAL 600.0190
GLU 610.0408
LYS 620.0294
PHE 630.0076
LEU 640.0273
LYS 650.0267
ARG 660.0342
ALA 670.0430
GLU 680.0367
ASN 690.0570

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.